Technological innovation

　　Since winning the Geneva Invention Gold Medal in 1998, Qizheng’s journey of innovation has never ceased: using modern preparation techniques to tackle persistent challenges in traditional Tibetan medicine, developing a green manufacturing process for modern Tibetan medicine, validating traditional Tibetan medicine through modern medical research, exploring innovative academic marketing models for ethnic medicines, and integrating resources to create an advanced R&D platform...

　　For over 20 years, Qizheng Tibetan Medicine has not only continuously innovated and driven industrial progress, but has also promoted the advancement and sustainable development of all stakeholders along the value chain. This has enabled joint progress with its partners and fostered the sustainable development of the regional economy.

　　In the future, as it collaborates with an even broader range of value-chain partners, Qizheng will continue to explore further along the two dimensions of “innovation” and “sharing,” thereby realizing shared value for a sustainable economy.

　　Build green manufacturing processes and become an environmentally friendly enterprise.

　　While preserving the traditional Tibetan medicine manufacturing processes, the company actively promotes clean production through technological and process innovation, implements comprehensive pollution control throughout the entire production cycle, continuously reduces its environmental footprint, achieves energy savings and emission reductions, and places great emphasis on resource conservation and integrated utilization during production. The company generates no harmful waste and is committed to developing a green manufacturing process for Tibetan medicine.

　　The company actively promotes green office practices across all its office locations, advocating that environmental protection starts with small daily actions. The company makes rational arrangements for commuting, reception, office operations, and freight transportation. Given the company’s multi-location office setup, we have vigorously promoted video and online conferencing systems, reducing the frequency of business trips and effectively minimizing the environmental impact caused by business travel.

　　Exploring the Modern Medical Value of Tibetan Medicine

　　The company leverages modern pharmaceutical technologies to study the mechanisms of action behind traditional Tibetan medicines, thereby validating their therapeutic effects and guiding clinical drug use. Moreover, it is developing some of these distinctive mechanisms into platforms for screening new drugs. At the same time, by drawing on research into the traditional theories of Tibetan medicine, the company aims to uncover new markets, applications, and directions for these time-honored remedies.

　　As early as 1996, when the Xiaotong Paste entered the market, the company began conducting post-marketing studies on the product. Starting in 2005, the company has carried out large-scale, focused post-marketing studies successively on Xiaotong Paste, Qingpeng Ointment, Baimai Ointment, Honghua Ruyi Pills, and other key products. To date, the company has published over 500 research papers related to post-marketing studies.

　　In its early days, the company leveraged cultural marketing to open the door for Tibetan medicine to enter the vast mainland market. As the medical market environment has evolved and consumers have become increasingly sophisticated, the company has continuously innovated its marketing strategies, fully promoting the academic value of Tibetan medicine and enhancing its influence in the mainstream pharmaceutical market.

　　Transform corporate innovation into social innovation.

　　In the social environment of mass innovation and widespread entrepreneurship, Qizheng is firmly rooted in its own enterprise while continuously innovating and upgrading its R&D platform. We are promoting the establishment of an open, boundary-less research institute that fully leverages the platform’s public-benefit and open characteristics. By pooling together diverse superior resources and specialized talents, and guided by industry needs, we are constantly propelling corporate innovation toward a new starting point of socially-driven innovation.

　　Jointly establish the Tibet Tibetan Medicine Engineering and Technology Research Center with the Tibet Autonomous Region Tibetan Hospital and the Tibet Tibetan Medical College;

　　Established the “Tibetan Medicine Research Laboratory” in collaboration with Professor David Christiani from Harvard University in the United States.

　　Established the “Natural Medicines Laboratory” in collaboration with the Lanzhou Branch of the Chinese Academy of Sciences;

　　Initiate the establishment of the Gansu Longyao Industry Association;

　　In collaboration with research institutes both within and outside Gansu Province, we are initiating the establishment of the “Gansu Provincial Institute for Modern Pharmaceutical Engineering of Traditional Chinese Medicine.”

　　We have achieved several firsts in the field of Tibetan medicine.

　　In 1996, Qizheng established the first in-house, professionally trained academic marketing team in the field of Tibetan medicine.

　　In 1998, the new technology of low-temperature vacuum freeze-drying was first applied to the production of Tibetan medicine, maximizing the preservation of the active ingredients in medicinal herbs and ensuring the efficacy of the products. The pain-relieving plaster won the Gold Award for International Invention at the Geneva International Exhibition.

　　In 2000, Qizheng Gannan Fogu Company became the first Tibetan medicine factory in China to obtain GMP certification.

　　In 2000, the first batch of new Tibetan medicine pills—such as the white pills—featuring film-coating technology rolled off the production line at Foge Company.

　　In 2000, the first Qingpeng Ointment—featuring a novel excipient and vacuum emulsification technology—was launched, pioneering the modernization of Tibetan medicine ointment formulations.

　　In 2001, the Xiantong Paste won the Second Prize of the National Science and Technology Progress Award, marking a breakthrough from zero in the history of national science and technology awards in Tibet.

　　In 2004, Qizheng applied hot-press coating technology to the production of Tiebangchui Pain Relief Ointment and Shangshi Pain Relief Ointment, achieving green production in the rubber plaster industry.

　　In 2006, the sales of Xiaotong Tie Gao were ranked first among Chinese traditional medicine surgical products in China's over-the-counter (OTC) drug category.

　　In 2008, the production technology for pain-relieving plaster patches reached a new milestone: the first domestically developed integrated machine for manufacturing medicinal cores and patches tailored to special dosage forms was put into operation, enabling standardized, automated, and large-scale production of the product.

　　In 2008, Qizheng was awarded the title of one of the first batch of National Innovative Enterprises.

　　In 2009, two national-local joint laboratories—focused on solid dosage forms and topical preparations of Tibetan medicine—were established at Qizheng.

　　In 2009, leveraging its strong innovative capabilities in Tibetan medicine, Qizheng was recognized as one of the first state-approved enterprise technology centers in Tibet.

　　In 2009, Qizheng Tibetan Medicine became the first Tibetan enterprise to be listed on the SME Board of the Shenzhen Stock Exchange.

　　In 2011, the first randomized, double-blind, placebo-controlled trial of a Tibetan medicine (Qingpeng Ointment) was successfully completed.

　　In 2013, Xiaotong Tie Gao became the first Tibetan medicine topical formulation to be included in the National Essential Medicines List.

　　In 2014, a pharmacoeconomic study involving more than 3,000 cases of Xiaotong Tie Gao was completed, pioneering the field of economic evaluations for Tibetan medicines.

　　In 2014, Honghua Ruyi Wan became the first Tibetan medicine to be incorporated into Western medical gynecological clinical practice guidelines and received the First Prize for Scientific and Technological Progress in the inaugural National Ethnic Medicine Science and Technology Awards.

In 2018, we undertook the Ministry of Industry and Information Technology’s “Comprehensive Standardization and New Model Application for Intelligent Manufacturing” project—“Construction of an Intelligent Factory for Tibetan Medicine Topical Preparations Based on Independently Developed Core Intelligent Equipment.”

In 2019, we undertook a demonstration development study under the National Key Research and Development Program—focusing on the classic Tibetan medicine Ru Yi Zhen Bao Pian and Bai Mai Ointment for the treatment of Bai Mai Disease, a major Tibetan medical condition.

In 2019, I undertook a sub-project under the National Key Research and Development Program titled “Construction of an Information Platform for Collaborative Evaluation of Ethnic Medicinal Resources such as Tibetan, Mongolian, and Uyghur Medicines, along with Research on Species Cataloging and Propagation & Conservation Technologies.”

In 2021, it was recognized by the Ministry of Industry and Information Technology of China as a “National Demonstration Enterprise for Technological Innovation.”

In 2021, the subsidiary Gansu Qizheng Tibetan Medicine Co., Ltd. was awarded the provincial titles of “Specialized, Fine, and New” and “Technology Innovation Demonstration” enterprise.

In 2022, the company was listed in the "Top 50 Chinese Traditional Chinese Medicine R&D Strength Ranking 2022," ranking 31st.

In 2023, the company’s project “Construction and Application of a Modern Research Model for Tibetan Medicine Guided by Tibetan Medical Theory” was awarded the Second Prize for Science and Technology of the Tibet Autonomous Region.